Advertisement

Click here for more guidelines.

 
 




CME Topic Collections Past Issues Search Current Issue Home
     

J Am Coll Cardiol, 1991; 18:152-156
© 1991 by the American College of Cardiology Foundation
This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Friedman, R.
Right arrow Articles by Garson, A
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Friedman, R.
Right arrow Articles by Garson, A, Jr

Clinical course of idiopathic dilated cardiomyopathy in children

RA Friedman, JP Moak, and A Garson Jr

Lillie Frank Abercrombie Section of Cardiology, Department of Pediatrics, Baylor College of Medicine, Houston, Texas.

Previous studies in adults with dilated cardiomyopathy suggest that the presence of arrhythmia, especially ventricular tachycardia, correlates with increased mortality. We performed a retrospective analysis of 63 children with idiopathic dilated cardiomyopathy to determine the prognostic significance of arrhythmias and other findings with respect to mortality. The mean age at diagnosis of the cardiomyopathy was 4.96 +/- 5.3 years. The overall mortality rate was 16% over a 10 year follow-up period. Persistent congestive heart failure and ST-T wave changes correlated with increased mortality (p less than 0.05). No other variables affected outcome. Arrhythmias were found in 46% of the patients; of the arrhythmias, 48% were atrial arrhythmias. Ventricular tachycardia was present in six patients. Death occurred in 4 (14%) of 29 patients with known arrhythmia; 1 of the 5 died suddenly. The remaining 6 deaths in the series occurred in the 34 patients without a documented arrhythmia. It is concluded that 1) arrhythmias are frequently seen in children with dilated cardiomyopathy but are not predictive of outcome; 2) sudden death in children with this disease is rare; and 3) persistent congestive heart failure portends a poor prognosis.


This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
E. Pahl, L. A. Sleeper, C. E. Canter, D. T. Hsu, M. Lu, S. A. Webber, S. D. Colan, P. F. Kantor, M. D. Everitt, J. A. Towbin, et al.
Incidence of and Risk Factors for Sudden Cardiac Death in Children With Dilated Cardiomyopathy: A Report From the Pediatric Cardiomyopathy Registry
J. Am. Coll. Cardiol., February 7, 2012; 59(6): 607 - 615.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. E. Andrews, M. J. Fenton, D. A. Ridout, M. Burch, and on Behalf of the British Congenital Cardiac Associ
New-Onset Heart Failure Due to Heart Muscle Disease in Childhood: A Prospective Study in the United Kingdom and Ireland
Circulation, January 1, 2008; 117(1): 79 - 84.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
P. E. F. Daubeney, A. W. Nugent, P. Chondros, J. B. Carlin, S. D. Colan, M. Cheung, A. M. Davis, C.W. Chow, R. G. Weintraub, and on behalf of the National Australian Childhood Car
Clinical Features and Outcomes of Childhood Dilated Cardiomyopathy: Results From a National Population-Based Study
Circulation, December 12, 2006; 114(24): 2671 - 2678.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
C. T. Spencer, R. M. Bryant, J. Day, I. L. Gonzalez, S. D. Colan, W. R. Thompson, J. Berthy, S. P. Redfearn, and B. J. Byrne
Cardiac and Clinical Phenotype in Barth Syndrome
Pediatrics, August 1, 2006; 118(2): e337 - e346.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al.
AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation In Collaboration With the Heart Rhythm Society
J. Am. Coll. Cardiol., January 17, 2006; 47(2): 473 - 484.
[Full Text] [PDF]


Home page
CirculationHome page
S. A. Strickberger, D. W. Benson, I. Biaggioni, D. J. Callans, M. I. Cohen, K. A. Ellenbogen, A. E. Epstein, P. Friedman, J. Goldberger, P. A. Heidenreich, et al.
AHA/ACCF Scientific Statement on the Evaluation of Syncope: From the American Heart Association Councils on Clinical Cardiology, Cardiovascular Nursing, Cardiovascular Disease in the Young, and Stroke, and the Quality of Care and Outcomes Research Interdisciplinary Working Group; and the American College of Cardiology Foundation: In Collaboration With the Heart Rhythm Society: Endorsed by the American Autonomic Society
Circulation, January 17, 2006; 113(2): 316 - 327.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
C. T. Maguire, H. Wakimoto, V. V. Patel, P. E. Hammer, K. Gauvreau, and C. I. Berul
Implications of ventricular arrhythmia vulnerability during murine electrophysiology studies
Physiol Genomics, September 29, 2003; 15(1): 84 - 91.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
E. Azeka, J. A. Franchini Ramires, C. Valler, and E. Alcides Bocchi
Delisting of infants and children from the heart transplantation waiting list after carvedilol treatment
J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2034 - 2038.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. I. Berul, B. K. McConnell, H. Wakimoto, I. P.G. Moskowitz, C. T. Maguire, C. Semsarian, M. M. Vargas, J. Gehrmann, C. E. Seidman, and J. G. Seidman
Ventricular Arrhythmia Vulnerability in Cardiomyopathic Mice With Homozygous Mutant Myosin-Binding Protein C Gene
Circulation, November 27, 2001; 104(22): 2734 - 2739.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
P Acar, P Merlet, L Iserin, D Bonnet, D Sidi, A Syrota, and J Kachaner
Impaired cardiac adrenergic innervation assessed by MIBG imaging as a predictor of treatment response in childhood dilated cardiomyopathy
Heart, June 1, 2001; 85(6): 692 - 696.
[Abstract] [Full Text]


Home page
PediatricsHome page
E. Helton, R. Darragh, P. Francis, F. J. Fricker, K. Jue, G. Koch, D. Mair, M. E. Pierpont, J. V. Prochazka, L. S. Linn, et al.
Metabolic Aspects of Myocardial Disease and a Role for L-Carnitine in the Treatment of Childhood Cardiomyopathy
Pediatrics, June 1, 2000; 105(6): 1260 - 1270.
[Abstract] [Full Text] [PDF]


Home page
PediatricsHome page
A. Arola, J. Tuominen, O. Ruuskanen, and E. Jokinen
Idiopathic Dilated Cardiomyopathy in Children: Prognostic Indicators and Outcome
Pediatrics, March 1, 1998; 101(3): 369 - 376.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. R. Costanzo, S. Augustine, R. Bourge, M. Bristow, J. B. O'Connell, D. Driscoll, and E. Rose
Selection and Treatment of Candidates for Heart Transplantation : A Statement for Health Professionals From the Committee on Heart Failure and Cardiac Transplantation of the Council on Clinical Cardiology, American Heart Association
Circulation, December 15, 1995; 92(12): 3593 - 3612.
[Abstract] [Full Text]


Home page
J Child NeurolHome page
S. Winter, K. Jue, J. Prochazka, P. Francis, W. Hamilton, L. Linn, and E. Helton
The Role of L-Carnitine in Pediatric Cardiomyopathy
J Child Neurol, November 1, 1995; 10(2_suppl): 2S45 - 2S51.
[Abstract] [PDF]



 
  CME Topic Collections Past Issues Search Current Issue Home

Advertisement